Timolol 0.5% Eye Drops for Essential Tremor: First Successful Case Report.

Area of Science:

• Neurology
• Ophthalmology
• Pharmacology

Background:

• Essential tremor (ET) is a common neurological disorder.
• Current treatments, primarily oral beta-blockers, may not be suitable for all patients due to side effects or the need for daily dosing.
• There is a need for alternative, episodic treatment options for ET.

Observation:

• This study explores the use of timolol 0.5% eye drops as a potential treatment for essential tremor.
• The formulation can be applied topically to the eyes or administered as a compounded nasal spray.
• The proposed application is for episodic use, targeting specific occasions where tremor control is desired.

Findings:

• Timolol 0.5% eye drops represent a novel therapeutic modality for managing mild to moderate essential tremor.
• This treatment is particularly suitable for patients seeking on-demand tremor suppression.
• It offers an alternative for individuals who experience intolerance to daily oral beta-blocker therapy.

Implications:

• This represents a potential first-in-literature report on using timolol eye drops for essential tremor.
• The findings may pave the way for new, patient-centric treatment strategies for ET.
• Further research is warranted to establish efficacy, safety, and optimal dosing for this novel application.